Daan Gene Co Ltd
SZSE:002030
Intrinsic Value
Daan Gene Co., Ltd. engages in the research, development, production and sales of clinical testing reagents and instruments; and provision of clinical laboratory services. [ Read More ]
The intrinsic value of one Daan Gene Co Ltd stock under the Base Case scenario is 7.12 CNY. Compared to the current market price of 6.06 CNY, Daan Gene Co Ltd is Undervalued by 15%.
Valuation Backtest
Daan Gene Co Ltd
Run backtest to discover the historical profit from buying and selling Daan Gene Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Balance Sheet Decomposition
Daan Gene Co Ltd
Current Assets | 5.3B |
Cash & Short-Term Investments | 2.4B |
Receivables | 2.4B |
Other Current Assets | 508.9m |
Non-Current Assets | 5.7B |
Long-Term Investments | 2B |
PP&E | 2.5B |
Intangibles | 892.9m |
Other Non-Current Assets | 338.3m |
Current Liabilities | 1.7B |
Accounts Payable | 425.4m |
Accrued Liabilities | 759.2m |
Short-Term Debt | 390.8m |
Other Current Liabilities | 145.6m |
Non-Current Liabilities | 416.6m |
Long-Term Debt | 27.1m |
Other Non-Current Liabilities | 389.5m |
Earnings Waterfall
Daan Gene Co Ltd
Revenue
|
1B
CNY
|
Cost of Revenue
|
-531.4m
CNY
|
Gross Profit
|
506.8m
CNY
|
Operating Expenses
|
-955.8m
CNY
|
Operating Income
|
-449m
CNY
|
Other Expenses
|
153.8m
CNY
|
Net Income
|
-295.2m
CNY
|
Free Cash Flow Analysis
Daan Gene Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Daan Gene Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Daan Gene Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Daan Gene Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Daan Gene Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Daan Gene Co Ltd
According to Wall Street analysts, the average 1-year price target for Daan Gene Co Ltd is 14.58 CNY .
Shareholder Return
Price
Daan Gene Co Ltd
Average Annual Return | 55.25% |
Standard Deviation of Annual Returns | 118.26% |
Max Drawdown | -78% |
Market Capitalization | 8.5B CNY |
Shares Outstanding | 1 371 130 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Daan Gene Co., Ltd. engages in the research, development, production and sales of clinical testing reagents and instruments; and provision of clinical laboratory services. The company is headquartered in Guangzhou, Guangdong and currently employs 2,713 full-time employees. The company went IPO on 2004-08-09. The Company’s main products include fluorescence quantitative polymerase chain reaction (PCR) series, public health series, time-resolved series and enzyme-linked immunization series. The firm also provides independent medical clinical laboratory testing services. The firm operates its business in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Daan Gene Co Ltd stock under the Base Case scenario is 7.12 CNY.
Compared to the current market price of 6.06 CNY, Daan Gene Co Ltd is Undervalued by 15%.